Skip to main content
Clinical Trials/NCT05732740
NCT05732740
Completed
Not Applicable

Evaluating the Feasibility and Preliminary Effect of Empower@Home: Connected for Depression, Social Isolation, and Loneliness Among Older Adults.

University of Michigan1 site in 1 country37 target enrollmentJanuary 17, 2023

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Depression
Sponsor
University of Michigan
Enrollment
37
Locations
1
Primary Endpoint
Changes in Patient-Reported Outcomes Measurment Information Systems - Social Isolation.
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

This single-group trial will evaluate the feasibility and preliminary effect of a novel group-based cognitive behavioral therapy program for older adults with elevated depressive symptoms. Participants will complete the program remotely in small groups.

Detailed Description

Depression affects up to 40% of homebound seniors, but most do not receive psychotherapy due to various access barriers. This study focuses on developing community-based solutions to reduce access barriers. In a previously approved project HUM00207612, the investigators tested the feasibility of a novel internet-based cognitive behavioral therapy (iCBT) program called Empower@Home. This study will test an adapted version of Empower@Home called Empower@Home: Connected that is delivered in a group format and also addresses social isolation and loneliness. Recruitment methods include 1) referrals from social service agencies, 2) advertisements on social media, local news outlets, and the program website, and 3) research participant registries. The intervention involves attending 9 group sessions. The sessions are facilitated by a mental health professional and involve psychoeducational material, cognitive-behavioral therapy exercises, and socialization. Sessions will occur on 9 consecutive weeks and will last approximately 90 minutes. Participants will complete a comprehensive baseline assessment and post-test. Each assessment will take between 40-60 minutes to complete over the phone. Recruitment will occur between January and April 2023, 20-25 participants will be recruited. All participants will receive the intervention.

Registry
clinicaltrials.gov
Start Date
January 17, 2023
End Date
September 22, 2023
Last Updated
2 years ago
Study Type
Interventional
Study Design
Single Group
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Xiaoling Xiang

Assistant Professor

University of Michigan

Eligibility Criteria

Inclusion Criteria

  • \>=60 years
  • have at least mild depressive symptoms, based on PHQ-9 \>=8
  • are willing to participate

Exclusion Criteria

  • Probable cognitive impairment based on the Blessed Orientation, Memory, and Concentration scale (score \>9).
  • They do not speak English
  • have active suicidal ideation, defined as moderate to high risk based on the 6-item Columbia-Suicide Severity Rating Scale (C-SSRS)
  • Have a terminal illness or unstable physical health with a high risk of hospitalization within the next 3 months
  • Have severe vision impairment that can not be corrected
  • Have probable substance use disorders as assessed by the 4-item CAGE screener (\>=2 on the CAGE AND have not been sober for at least one year)
  • Have a self-reported psychotic disorder or bipolar disorder

Outcomes

Primary Outcomes

Changes in Patient-Reported Outcomes Measurment Information Systems - Social Isolation.

Time Frame: Change from baseline PROMIS-Social Isolation to post-test at 9 weeks

Changes in 8-item Patient-Reported Outcomes Measurment Information Systems - Social Isolation. PROMIS - SI scores range from 0 to 32, with higher scores indicating higher social isolation.

Changes in De Jong Gierveld Scale

Time Frame: Change from baseline De Jong Gierveld Scale to post-test at 9 weeks

Change in 6-item De Jong Gierveld Short Scale for Emotional and Social Loneliness. Scores range from 0 to 6, with higher scores indicating more loneliness.

Change in Patient Health Questionnaire-9

Time Frame: Change from baseline PHQ9 to post-test at 9 weeks

Changes in 9-item standardized measure of depression symptom severity. PHQ-9 scores range from 0 to 27, with higher scores indicating more depressive symptoms.

Secondary Outcomes

  • Changes in Generalized Anxiety Disorder Assessment-7(Change inGeneralized Anxiety Disorder Assessment-7 baseline to post-test at 9 weeks)
  • Changes in Patient-Reported Outcomes Measurment Information Systems- Global Health(Change from baseline PROMIS-Global Health to post-test at 9 weeks)
  • Changes in Health Related Quality of Life(Change from baseline Health-Related Quality of Life to post-test at 9 weeks)

Study Sites (1)

Loading locations...

Similar Trials